| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-05 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |